Grover A, Joshi A. An overview of chronic disease models: a systematic literature review. Glob J Health Sci. 2014;7(2):210–27. https://doi.org/10.5539/gjhs.v7n2p210.

Article  PubMed  PubMed Central  Google Scholar 

Griffith LE, Gilsing A, Mangin D, Patterson C, Heuvel E, Sohel N, et al. Multimorbidity frameworks impact prevalence and relationships with patient-important outcomes. J Am Geriatr Soc. 2019;67:1632–40. https://doi.org/10.1111/jgs.15921.

Article  PubMed  Google Scholar 

Spencer-Bonilla G, et al. Patient work and treatment burden in type 2 diabetes: a mixed-methods study. Mayo Clin Proc Innov Qual Outcomes. 2021;5(2):359–67. https://doi.org/10.1016/j.mayocpiqo.2021.01.006.

Article  PubMed  PubMed Central  Google Scholar 

Buffel du Vaure C, Ravaud P, Baron G, Barnes C, Gilberg S, Boutron I. Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis. BMJ Open. 2016;6(3):e010119. https://doi.org/10.1136/bmjopen-2015-010119.

Article  PubMed  PubMed Central  Google Scholar 

Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65(10):1041–51. https://doi.org/10.1016/j.jclinepi.2012.05.005.

Article  PubMed  Google Scholar 

Vijan S, Hayward RA, Ronis DL, Hofer TP. Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimen. J Gen Intern Med. 2005;20(5):479–82. https://doi.org/10.1111/j.1525-1497.2005.0117.x.

Article  PubMed  PubMed Central  Google Scholar 

Tran VT, Harrington M, Montori VM, Barnes C, Wicks P, Ravaud P. Adaptation and validation of the treatment burden questionnaire (TBQ) in English using an internet platform. BMC Med. 2014;12:109. https://doi.org/10.1186/1741-7015-12-109.

Article  PubMed  PubMed Central  Google Scholar 

Eton DT, et al. Development and validation of the patient experience with treatment and self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res. 2017;26(2):489–503. https://doi.org/10.1007/s11136-016-1397-0.

Article  PubMed  Google Scholar 

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https://doi.org/10.1186/s12877-017-0621-2.

Article  PubMed  PubMed Central  Google Scholar 

Jyrkkä J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf. 2011;20(5):514–22. https://doi.org/10.1002/pds.2116.

Article  PubMed  Google Scholar 

Mangin D, et al. International Group for Reducing Inappropriate Medication Use and Polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging. 2018;35(7):575–87. https://doi.org/10.1007/s40266-018-0554-2.

Article  PubMed  PubMed Central  Google Scholar 

Seppala LJ, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11-17. https://doi.org/10.1016/j.jamda.2017.12.098.

Article  PubMed  Google Scholar 

Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15–28. https://doi.org/10.2165/00002512-199915010-00002.

Article  CAS  PubMed  Google Scholar 

May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. 2009;339:b2803. https://doi.org/10.1136/bmj.b2803.

Article  PubMed  Google Scholar 

Montori V. Why we revolt: a patient revolution for careful and kind care. Rochester: The Patient Revolution; 2017.

Google Scholar 

Mangin D, Heath I, Jamoulle M. Beyond diagnosis: rising to the multimorbidity challenge. BMJ. 2012;344:e3526. https://doi.org/10.1136/bmj.e3526.

Article  PubMed  Google Scholar 

Tinetti ME, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95. https://doi.org/10.1001/jamainternmed.2013.14764.

Article  PubMed  PubMed Central  Google Scholar 

Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86–8. https://doi.org/10.1038/clpt.2008.224.

Article  CAS  PubMed  Google Scholar 

Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. https://doi.org/10.1517/14740338.2013.827660.

Article  PubMed  Google Scholar 

Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75 + study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493–503. https://doi.org/10.2165/00002512-200926060-00006.

Article  PubMed  Google Scholar 

Thompson W, Farrell B. Deprescribing: what is it and what does the evidence tell us? Can J Hosp Pharm. 2013;66(3):201–2. https://doi.org/10.4212/cjhp.v66i3.1261.

Article  PubMed  PubMed Central  Google Scholar 

Tannenbaum C, et al. An ecological approach to reducing potentially inappropriate medication use: Canadian Deprescribing Network. Can J Aging. 2017;36(1):97–107. https://doi.org/10.1017/s0714980816000702.

Article  PubMed  Google Scholar 

"Simpathy project." https://simpathy.eu/blog/. Accessed 17 Oct 2019.

Scott IA, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34. https://doi.org/10.1001/jamainternmed.2015.0324.

Article  PubMed  Google Scholar 

Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83. https://doi.org/10.5414/cpp46072.

Article  CAS  PubMed  Google Scholar 

American Geriatrics Society. 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.

Article  Google Scholar 

Kaufmann CP, Tremp R, Hersberger KE, Lampert ML. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70(1):1–11. https://doi.org/10.1007/s00228-013-1575-8.

Article  PubMed  Google Scholar 

Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24. https://doi.org/10.1001/jama.294.6.716.

Article  CAS  PubMed  Google Scholar 

Dreischulte T, Grant AM, McCowan C, McAnaw JJ, Guthrie B. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol. 2012;12:5. https://doi.org/10.1186/1472-6904-12-5.

Article  PubMed  PubMed Central  Google Scholar 

Mason JD, Colley CA. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial. Ann Pharmacother. 1993;27(5):555–9. https://doi.org/10.1177/106002809302700503.

Article  CAS  PubMed  Google Scholar 

Chisholm-Burns MA, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923–33. https://doi.org/10.1097/MLR.0b013e3181e57962.

Article  PubMed  Google Scholar 

Stuhec M. Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm. 2021;43(6):1722–7. https://doi.org/10.1007/s11096-021-01306-2.

Article  PubMed  Google Scholar 

Garfinkel D, Zur-Gil S, Ben-Israel H. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430.

PubMed  Google Scholar 

Mangin D, Stephen G, Bismah V, Risdon C. Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. BMJ Open. 2016;6(6):e010903. https://doi.org/10.1136/bmjopen-2015-010903.

Article  PubMed  PubMed Central  Google Scholar 

Kutner JS, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175(5):691–700. https://doi.org/10.1001/jamainternmed.2015.0289.

Article  PubMed  PubMed Central  Google Scholar 

Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583–623. https://doi.org/10.1111/bcp.12975.

Article  PubMed  PubMed Central  Google Scholar 

Rankin A, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9(9):CD008165. https://doi